NCT06880341 Managing Transient Neurologic Episodes in Surgery for Moyamoya Disease
| NCT ID | NCT06880341 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Moya Moya Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 88 participants |
| Start Date | 2025-05-21 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 88 participants in total. It began in 2025-05-21 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to study the incidence of post-operative Transient Neurologic Events (TNEs) within 30 days postoperatively, as assessed by clinical neurological scales, binned by week. Collect data on all interventions and assessments performed during the recovery post surgery up to 30 days, to understand what factors might cause Transient Neurologic Events (TNEs) and determine how these can be reduced in Moyamoya subjects post surgery.
Eligibility Criteria
Inclusion Criteria: * Moyamoya Disease (MMD) patients undergoing direct extracranial-intracranial (ECIC) bypass. Patients above the age of 3 years old are eligible for the study Exclusion Criteria: * Renal dysfunction, electrolyte disturbances neuromuscular disorders including Myaesthenia Gravis, heart block
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06880341 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, studying Moya Moya Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06880341 currently recruiting?
Yes, NCT06880341 is actively recruiting participants. Contact the research team at jine7000@stanford.edu for enrollment information.
Where is the NCT06880341 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT06880341 clinical trial?
NCT06880341 is sponsored by Stanford University. The trial plans to enroll 88 participants.